<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" xml:lang="es"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurologia</journal-id><journal-id journal-id-type="iso-abbrev">Neurologia</journal-id><journal-title-group><journal-title>Neurologia (Barcelona, Spain)</journal-title></journal-title-group><issn pub-type="ppub">0213-4853</issn><issn pub-type="epub">1578-1968</issn><publisher><publisher-name>Sociedad Espa&#x000f1;ola de Neurolog&#x000ed;a. Published by Elsevier Espa&#x000f1;a, S.L.U.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7136883</article-id><article-id pub-id-type="publisher-id">S0213-4853(20)30065-7</article-id><article-id pub-id-type="doi">10.1016/j.nrl.2020.03.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>&#x000bf;Es esperable que haya cuadros neurol&#x000f3;gicos por la pandemia por SARS-CoV-2?</article-title><trans-title-group xml:lang="en"><trans-title>Should we expect neurological symptoms in the SARS-CoV-2 epidemic?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Mat&#x000ed;as-Guiu</surname><given-names>J.</given-names></name><email>neurol.hcsc@salud.madrid.org</email><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Gomez-Pinedo</surname><given-names>U.</given-names></name></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Montero-Escribano</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Gomez-Iglesias</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Porta-Etessam</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author" id="aut0030"><name><surname>Matias-Guiu</surname><given-names>J.A.</given-names></name></contrib><aff id="aff0005">Servicio de Neurolog&#x000ed;a, Instituto de Neurociencias, Hospital Cl&#x000ed;nico San Carlos, San Carlos, IdISSC, Madrid, Espa&#x000f1;a</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Autor para correspondencia. <email>neurol.hcsc@salud.madrid.org</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>6</day><month>4</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>4</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>6</day><month>4</month><year>2020</year></pub-date><volume>35</volume><issue>3</issue><fpage>170</fpage><lpage>175</lpage><history><date date-type="received"><day>27</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Sociedad Espa&#x000f1;ola de Neurolog&#x000ed;a. Published by Elsevier Espa&#x000f1;a, S.L.U.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Sociedad Espa&#x000f1;ola de Neurolog&#x000ed;a</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><title>Resumen</title><sec><title>Introducci&#x000f3;n</title><p>Diversas evidencias sugieren que el SARS-CoV-2 puede penetrar en el sistema nervioso central (SNC). Los autores revisan los datos de la literatura sobre los hallazgos de coronavirus en el SNC asociado a enfermedades neurol&#x000f3;gicas.</p></sec><sec><title>Desarrollo</title><p>En las distintas epidemias con SARS-CoV y MERS-CoV la presencia de cuadros neurol&#x000f3;gicos es baja, pero se describen cuadros aislados de pacientes. Tambi&#x000e9;n existen casos asociados a OC43-CoV y 229E-CoV. La existencia de lesiones neurol&#x000f3;gicas, especialmente desmielinizantes en el modelo MHV-CoV pueden explicar mecanismos de penetraci&#x000f3;n de los CoV en el SNC y especialmente aquellos relacionados con la respuesta inmune, que puede justificar la existencia de CoV en pacientes con esclerosis m&#x000fa;ltiple. Los autores revisan aspectos diferenciales de SARS-CoV-2 y se plantean si debido al alto n&#x000fa;mero de infectados, el virus puede afectar de forma mayor al SNC.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Aunque la presencia de s&#x000ed;ntomas neurol&#x000f3;gicos en las epidemias de CoV es baja, la mayor frecuencia de infectados por SARS-CoV-2 podr&#x000ed;a justificar el paso del virus y la posibilidad de cl&#x000ed;nica neurol&#x000f3;gica precoz o tard&#x000ed;a con mayor incidencia. El seguimiento de los pacientes de la epidemia debe atender con cuidado a la evaluaci&#x000f3;n del SNC.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases.</p></sec><sec><title>Development</title><p>Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement.</p></sec><sec><title>Conclusion</title><p>Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS.</p></sec></trans-abstract><kwd-group id="kwd0005"><title>Palabras clave</title><kwd>Coronavirus</kwd><kwd>SARS-CoV</kwd><kwd>MERS-CoV</kwd><kwd>Esclerosis m&#x000fa;ltiple</kwd><kwd>SARS-CoV-2</kwd><kwd>Virus murino de la hepatitis</kwd><kwd>S&#x000ed;ntomas neurol&#x000f3;gicos</kwd><kwd>Sistema nervioso central</kwd></kwd-group><kwd-group xml:lang="en" id="kwd0010"><title>Keywords</title><kwd>Coronavirus</kwd><kwd>SARS-CoV</kwd><kwd>MERS-CoV</kwd><kwd>Multiple sclerosis</kwd><kwd>SARS-CoV-2</kwd><kwd>Mouse hepatitis virus</kwd><kwd>Neurological symptoms</kwd><kwd>Central nervous system</kwd></kwd-group></article-meta></front><body><p id="par0005">La asociaci&#x000f3;n a coronavirus que infectaban a humanos estaba asociada a enfermedades menores del sistema respiratorio superior e inferior tanto en ni&#x000f1;os como en adultos. Los 4 coronavirus humanos end&#x000e9;micos 229E-CoV, NL63-CoV, OC43-CoV y HKU1-CoV han estado considerados entre las causas del resfriado com&#x000fa;n. Dos de ellos est&#x000e1;n considerados como &#x003b1;CoV (229E-CoV y NL63-CoV) y 2 de ellos como &#x003b2;CoV (OC43-CoV y HKU1-CoV)<xref rid="bib0450" ref-type="bibr"><sup>1</sup></xref>. Dos nuevos coronavirus, tambi&#x000e9;n &#x003b2;CoV (SARS-CoV y MERS-CoV9) se han comportado de forma mucho m&#x000e1;s agresiva, en forma de epidemias con pacientes que presentaron manifestaciones extrapulmonares e incluso muerte. As&#x000ed;, en 2003, SARS-CoV fue identificado como la causa de un cuadro respiratorio grave que apareci&#x000f3; por primera vez en la provincia de Guangdong, China, y m&#x000e1;s tarde, en 2004, MERS-CoV fue el responsable de una epidemia que tuvo su mayor impacto en la Pen&#x000ed;nsula Ar&#x000e1;bica. El 31 de diciembre de 2019, la OMS comunica de casos de neumon&#x000ed;a en la ciudad de Wuhan, provincia de Hubei, China, en que se demuestra la presencia de un nuevo CoV, 2019-nCoV (SARS-CoV-2), cuya difusi&#x000f3;n se realiza r&#x000e1;pidamente en China y en el resto del mundo, y que se encuentra dentro de las caracter&#x000ed;sticas del &#x003b2;-CoV, con una similitud bastante amplia a SARS-CoV. La pandemia por SARS-CoV-2 est&#x000e1; llegando a todo el mundo, con una amplia mortalidad y un amplio impacto social que vivimos en la actualidad, y que probablemente acabar&#x000e1; afectando a un gran n&#x000fa;mero de personas.</p><p id="par0010">El sistema nervioso central (SNC) es vulnerable a los virus, y muchos de ellos acaban llegando al cerebro como el virus del herpes<xref rid="bib0455" ref-type="bibr"><sup>2</sup></xref>, los arbovirus<xref rid="bib0460" ref-type="bibr"><sup>3</sup></xref>, el sarampi&#x000f3;n<xref rid="bib0465" ref-type="bibr"><sup>4</sup></xref>, la influenza y el VIH<xref rid="bib0470" ref-type="bibr"><sup>5</sup></xref>, entre otros. Los coronavirus tambi&#x000e9;n pueden actuar sobre el SNC<xref rid="bib0475" ref-type="bibr">6</xref>, <xref rid="bib0480" ref-type="bibr">7</xref>, y en consecuencia una pandemia con un n&#x000fa;mero tan alto de afectados podr&#x000ed;a suponer la aparici&#x000f3;n de cuadros neurol&#x000f3;gicos. La presente revisi&#x000f3;n pretende analizar la informaci&#x000f3;n existe sobre la acci&#x000f3;n de los coronavirus humanos en el SNC.</p><sec id="sec0005"><title>Cuadro neurol&#x000f3;gicos por coronavirus</title><p id="par0015">Es indudable que los CoV penetran en el SNC. Se han detectado RNA de CoV en el sistema nervioso central de pacientes con diversas enfermedades neurol&#x000f3;gicas<xref rid="bib0485" ref-type="bibr">8</xref>, <xref rid="bib0490" ref-type="bibr">9</xref>, y ello ha tenido una traducci&#x000f3;n cl&#x000ed;nica en cuadros encefal&#x000ed;ticos en ni&#x000f1;os<xref rid="bib0495" ref-type="bibr"><sup>10</sup></xref> y tambi&#x000e9;n se han observado meningitis, y en el s&#x000ed;ndrome de Guillain-Barr&#x000e9; u otras enfermedades de base neuroinmunitaria<xref rid="bib0500" ref-type="bibr">11</xref>, <xref rid="bib0505" ref-type="bibr">12</xref>, <xref rid="bib0510" ref-type="bibr">13</xref>, <xref rid="bib0515" ref-type="bibr">14</xref>, <xref rid="bib0520" ref-type="bibr">15</xref>. Asimismo, se han observado en el contexto de infecciones por CoV<xref rid="bib0525" ref-type="bibr">16</xref>, <xref rid="bib0530" ref-type="bibr">17</xref>. Entre los CoV, OC43-CoV ha sido considerado como un virus con mayor capacidad neuroinvasiva, ya que se ha demostrado que invade, se propaga y persiste dentro del SNC en el rat&#x000f3;n, afectando directamente a los neuronas<xref rid="bib0535" ref-type="bibr">18</xref>, <xref rid="bib0540" ref-type="bibr">19</xref> y se ha descrito que utiliza el transporte axonal para su difusi&#x000f3;n<xref rid="bib0545" ref-type="bibr"><sup>20</sup></xref>. OC43-CoV tiene la capacidad de inducir degeneraci&#x000f3;n y muerte celular<xref rid="bib0550" ref-type="bibr">21</xref>, <xref rid="bib0555" ref-type="bibr">22</xref>, <xref rid="bib0560" ref-type="bibr">23</xref>. En el humano se ha detectado este virus en muestras del cerebro humano de pacientes que padecen enfermedades neurol&#x000f3;gicas como Alzheimer, enfermedad de Parkinson y esclerosis m&#x000fa;ltiple (EM), y en sanos. Asimismo, se ha asociado de forma similar a 229E-CoV a la presencia de convulsiones febriles<xref rid="bib0565" ref-type="bibr"><sup>24</sup></xref>. Adem&#x000e1;s, OC43-CoV fue detectado en el cerebro de un ni&#x000f1;o inmunodeficiente que muri&#x000f3; de encefalitis<xref rid="bib0570" ref-type="bibr"><sup>25</sup></xref>. Ambos virus, OC43-CoV y 229E-CoV tienen la capacidad de entrar en las c&#x000e9;lulas de la inmunidad innata<xref rid="bib0575" ref-type="bibr">26</xref>, <xref rid="bib0580" ref-type="bibr">27</xref>.</p></sec><sec id="sec0010"><title>MERS-CoV y SARS-CoV</title><p id="par0020">SARS-CoV y el MERS-CoV pueden causar una infecci&#x000f3;n grave del tracto respiratorio inferior con s&#x000ed;ndrome de dificultad respiratoria aguda y manifestaciones extrapulmonares como diarrea, linfopenia, pruebas de funci&#x000f3;n hep&#x000e1;tica y renal alteradas, y s&#x000ed;ndrome de disfunci&#x000f3;n multiorg&#x000e1;nica, tanto entre hu&#x000e9;spedes inmunocompetentes como inmunocomprometidos con tasas de mortalidad superior al 10%, aunque existen casos asintom&#x000e1;ticos<xref rid="bib0585" ref-type="bibr"><sup>28</sup></xref>. Ambos virus han sido responsables de 2 epidemias con un n&#x000fa;mero alto de personas contagiadas. La presencia de cuadros neurol&#x000f3;gicos no ha sido alta en los diferentes estudios, aunque todos ellos analizan la fase inicial de la epidemia. Un estudio retrospectivo en Arabia Saudita se encontr&#x000f3; que el 25,7% de los pacientes con MERS desarrollaron confusi&#x000f3;n y el 8,6% experiment&#x000f3; convulsiones<xref rid="bib0590" ref-type="bibr"><sup>29</sup></xref>. Solo 4 casos con afectaci&#x000f3;n del SNC (encefalomielitis diseminada aguda, accidente cerebrovascular y encefalitis) y un caso con polineuropat&#x000ed;a de enfermedad cr&#x000ed;tica ha sido reportado para pacientes con MERS<xref rid="bib0595" ref-type="bibr">30</xref>, <xref rid="bib0600" ref-type="bibr">31</xref>. Tambi&#x000e9;n se ha descrito la presencia s&#x000ed;ndrome de Guillain-Barr&#x000e9; y neuropat&#x000ed;a perif&#x000e9;rica de aparici&#x000f3;n tard&#x000ed;a, y en alg&#x000fa;n paciente se describe el cronograma entre la presencia del cuadro infeccioso y el neurol&#x000f3;gico<xref rid="bib0605" ref-type="bibr"><sup>32</sup></xref>. Existe un caso descrito asociado a una hemorragia cerebral en la que los autores consideran que el paciente no ten&#x000ed;a riesgo de presentar el cuadro por otro origen<xref rid="bib0610" ref-type="bibr"><sup>33</sup></xref>. Un estudio <italic>in vitro</italic> ha observado que MERS-CoV tiene una especial sensibilidad para invadir diversas l&#x000ed;neas celulares espec&#x000ed;ficas y halla que entre ellas muestra la capacidad de infectar c&#x000e9;lulas neuronales humanas<xref rid="bib0615" ref-type="bibr"><sup>34</sup></xref>. La cuesti&#x000f3;n de que las complicaciones neurol&#x000f3;gicas halladas con MERS-CoV son de aparici&#x000f3;n tard&#x000ed;a, la ausencia del virus en el LCR y la presencia de cuadros de s&#x000ed;ndrome de Guillain-Barr&#x000e9; no est&#x000e1; aclarado y puede estar relacionada con la respuesta inmune<xref rid="bib0620" ref-type="bibr"><sup>35</sup></xref>. Algunos autores han se&#x000f1;alado que la falta de hallazgos del virus en muestras biol&#x000f3;gicas puede ser debido a cuestiones metodol&#x000f3;gicas<xref rid="bib0625" ref-type="bibr"><sup>36</sup></xref>. Durante el brote por SARS-CoV en 2002-2003, la descripci&#x000f3;n de cuadros neurol&#x000f3;gicos fue baja<xref rid="bib0630" ref-type="bibr"><sup>37</sup></xref> y con casos aislados<xref rid="bib0635" ref-type="bibr"><sup>38</sup></xref>. Seis pacientes que desarrollaron polineuropat&#x000ed;a axonal al mes despu&#x000e9;s del inicio del SARS mejoraron en el seguimiento. Tambi&#x000e9;n hubo pacientes que experimentaron alteraciones neuromusculares<xref rid="bib0640" ref-type="bibr"><sup>39</sup></xref> como miopat&#x000ed;a<xref rid="bib0645" ref-type="bibr"><sup>40</sup></xref> y rabdomi&#x000f3;lisis. SARS fue un cuadro m&#x000e1;s grave<xref rid="bib0650" ref-type="bibr"><sup>41</sup></xref>, de forma que se ha sugerido que estas alteraciones musculares podr&#x000ed;an ser debidas m&#x000e1;s a la situaci&#x000f3;n cr&#x000ed;tica de los pacientes que al propio virus. Se describieron tambi&#x000e9;n la presencia de ictus<xref rid="bib0655" ref-type="bibr">42</xref>, <xref rid="bib0660" ref-type="bibr">43</xref>.</p></sec><sec id="sec0015"><title>Coronavirus y esclerosis m&#x000fa;ltiple</title><p id="par0025">Los CoV han sido propuestos como una hip&#x000f3;tesis de asociaci&#x000f3;n ambiental a la EM<xref rid="bib0665" ref-type="bibr"><sup>44</sup></xref>. Ello ha sido apoyado por varios argumentos. Se han detectado part&#x000ed;culas similares a coronavirus en el tejido cerebral autopsiado de un paciente con EM<xref rid="bib0670" ref-type="bibr"><sup>45</sup></xref>. CoV se han aislado en el cerebro obtenido en la autopsia de 2 pacientes con EM<xref rid="bib0675" ref-type="bibr"><sup>46</sup></xref> y se ha obtenido RNA en el cerebro de otros pacientes<xref rid="bib0680" ref-type="bibr">47</xref>, <xref rid="bib0685" ref-type="bibr">48</xref>, <xref rid="bib0690" ref-type="bibr">49</xref>. Se ha observado la s&#x000ed;ntesis intratecal de anticuerpos anti-CoV humanos indicativos de una infecci&#x000f3;n del SNC en pacientes con EM<xref rid="bib0695" ref-type="bibr"><sup>50</sup></xref>. Se ha detectado RNA de CoV humanos. Se ha hallado RNA de CoV humanos en el LCR de pacientes con EM<xref rid="bib0700" ref-type="bibr"><sup>51</sup></xref>. Desde el punto de vista experimental se ha demostrado que CoV humanos pueden infectar neuronas, astrocitos y microgl&#x000ed;a en cultivos primarios<xref rid="bib0705" ref-type="bibr"><sup>52</sup></xref>, y tambi&#x000e9;n a c&#x000e9;lulas gliales humanas inmortalizadas<xref rid="bib0710" ref-type="bibr"><sup>53</sup></xref>. Es interesante que CoV humanos pueden infectar c&#x000e9;lulas de estirpe oligodendrocitaria y oligodendrocios<xref rid="bib0715" ref-type="bibr"><sup>54</sup></xref>. Asimismo, ha reforzado esta hip&#x000f3;tesis el hecho que las infecciones de las v&#x000ed;as respiratorias superiores de origen viral que pueden estar relacionadas con CoV humanos son un desencadenante importante de los brotes de EM<xref rid="bib0720" ref-type="bibr">55</xref>, <xref rid="bib0725" ref-type="bibr">56</xref>.</p></sec><sec id="sec0020"><title>El virus de la hepatitis de rat&#x000f3;n</title><p id="par0030">El MHV-CoA es un virus que afecta al rat&#x000f3;n<xref rid="bib0730" ref-type="bibr"><sup>57</sup></xref> y no al humano que induce trastornos neurol&#x000f3;gicos<xref rid="bib0735" ref-type="bibr">58</xref>, <xref rid="bib0740" ref-type="bibr">59</xref>, y ello ha posibilitado la creaci&#x000f3;n de un modelo experimental para estudiar el papel de los CoV en el SNC. Las cepas neurotr&#x000f3;picas de MHV pueden invadir el SNC por inoculaci&#x000f3;n intranasal en ratones<xref rid="bib0745" ref-type="bibr"><sup>60</sup></xref> y tambi&#x000e9;n por v&#x000ed;a sangu&#x000ed;nea, y ello se ha observado tambi&#x000e9;n en primates<xref rid="bib0750" ref-type="bibr"><sup>61</sup></xref>. El paso por la barrera hematoencefalica se ha relacionado con la producci&#x000f3;n de interfer&#x000f3;n-beta por las c&#x000e9;lulas epiteliales de la microcirculaci&#x000f3;n cerebral<xref rid="bib0755" ref-type="bibr"><sup>62</sup></xref>. La infecci&#x000f3;n por MHV-CoV desencadena una encefalomielitis aguda asociada con &#x000e1;reas focales de desmielinizaci&#x000f3;n, y se ha analizado el papel de la respuesta inmune en su evoluci&#x000f3;n<xref rid="bib0760" ref-type="bibr"><sup>63</sup></xref>. La activaci&#x000f3;n de la microgl&#x000ed;a, la descarga de mediadores inflamatorios generar&#x000ed;an un microambiente local del SNC que influir&#x000ed;a en la replicaci&#x000f3;n viral y lo que puede conducir a la desmielinizaci&#x000f3;n<xref rid="bib0765" ref-type="bibr"><sup>64</sup></xref>. Es por ello, que la aparici&#x000f3;n de lesiones desmielinizantes ha sugerido que este modelo podr&#x000ed;a ser aplicable al conocimiento de la EM.</p></sec><sec id="sec0025"><title>La epidemia de SARS-CoV-2 y la posibilidad de que el cerebro pueda ser reservorio del virus</title><p id="par0035">Aunque se asemeje, el nuevo virus es distinto a SARS-Cov<xref rid="bib0770" ref-type="bibr"><sup>65</sup></xref>, causante de la epidemia actual presenta diferencias gen&#x000e9;ticas y estructurales con los anteriores, y forma parte del grupo &#x003b2;CoV. Una de las caracter&#x000ed;sticas de este nuevo virus es que es altamente difundible<xref rid="bib0775" ref-type="bibr"><sup>66</sup></xref> y en mayor medida que SARS-CoV<xref rid="bib0780" ref-type="bibr"><sup>67</sup></xref>, propagado por gotas, contacto directo y contacto con objetos infectados, y que se propaga tambi&#x000e9;n con personas infectadas asintom&#x000e1;ticos<xref rid="bib0785" ref-type="bibr">68</xref>, <xref rid="bib0790" ref-type="bibr">69</xref>, <xref rid="bib0795" ref-type="bibr">70</xref>. Aunque existen distintos estudios observacionales que han analizado los s&#x000ed;ntomas de la enfermedad, la presencia de s&#x000ed;ntomas neurol&#x000f3;gicos es baja, salvo cefalea y cuadros vestibulares en estudios observaciones<xref rid="bib0800" ref-type="bibr">71</xref>, <xref rid="bib0805" ref-type="bibr">72</xref>, <xref rid="bib0810" ref-type="bibr">73</xref>, <xref rid="bib0815" ref-type="bibr">74</xref>, <xref rid="bib0820" ref-type="bibr">75</xref>, <xref rid="bib0825" ref-type="bibr">76</xref>, y en un estudio espec&#x000ed;fico en pacientes hospitalizados<xref rid="bib0830" ref-type="bibr"><sup>77</sup></xref> o casos aislados<xref rid="bib0835" ref-type="bibr"><sup>78</sup></xref> a pesar que algunos autores han se&#x000f1;alado de la posibilidad de que el virus pueda afectar al sistema nervioso central como en SARS-CoV en el que el virus se hall&#x000f3; en el cerebro de pacientes<xref rid="bib0840" ref-type="bibr"><sup>79</sup></xref>. Algunos datos cl&#x000ed;nicos parecen apuntar a unas caracter&#x000ed;sticas diferenciales como las alteraciones olfatorias, descrita por grupos alemanes por primera vez, y la presencia de alucinaciones que no han sido referidas por SARS-CoV ni MERS-CoV. El virus tiene algunas caracter&#x000ed;sticas que han apoyado que tenga una especial sensibilidad hacia el SNC.</p><p id="par0040">Las principales diferencias estructurales entre SARS-CoV y SARS-CoV-2 est&#x000e1; en la prote&#x000ed;na de fusi&#x000f3;n y en las prote&#x000ed;nas accesorias ORF3b y ORF8. El genoma del virus codifica 4 prote&#x000ed;nas estructurales principales, incluidas la espiga (S), la nucleoc&#x000e1;pside, la membrana y la envoltura que se requieren para formar la part&#x000ed;cula viral completa<xref rid="bib0845" ref-type="bibr"><sup>80</sup></xref>. Una glicoprote&#x000ed;na de la prote&#x000ed;na S puede ser un desencadenante de enfermedades neurodegenerativas<xref rid="bib0850" ref-type="bibr"><sup>81</sup></xref>. Al ingresar a las c&#x000e9;lulas hu&#x000e9;sped, el genoma viral se traduce en 2 poliprote&#x000ed;nas precursoras grandes que se procesan en 16 prote&#x000ed;nas no estructurales maduras (NSP1-NSP16) mediante proteinasas virales codificadas por ORF1a, entre otras. Estas nspS realizan una funci&#x000f3;n crucial durante la replicaci&#x000f3;n y transcripci&#x000f3;n del ARN viral<xref rid="bib0855" ref-type="bibr"><sup>82</sup></xref>, y ORF3b se ha relacionado con la respuesta inmune<xref rid="bib0860" ref-type="bibr"><sup>83</sup></xref>. La subunidad 1 de la prote&#x000ed;na de fusi&#x000f3;n se une tambi&#x000e9;n al receptor ACE2 como SARS-CoV, que es el lugar de enlace con el hu&#x000e9;sped y que ha planteado la posibilidad de crear un modelo experimental para la infecci&#x000f3;n<xref rid="bib0865" ref-type="bibr"><sup>84</sup></xref>. Un hecho relevante es que el cerebro tiene una expresi&#x000f3;n alta de receptores de ACE2<xref rid="bib0870" ref-type="bibr"><sup>85</sup></xref>, lo que ha sugerido que por esta raz&#x000f3;n en esta epidemia la penetraci&#x000f3;n del virus al SNC puede ser alta<xref rid="bib0875" ref-type="bibr"><sup>86</sup></xref>. Estudios previos demostraron la correlaci&#x000f3;n positiva de la expresi&#x000f3;n de ACE2 y la infecci&#x000f3;n de SARS-CoV <italic>in vitro</italic>
<xref rid="bib0880" ref-type="bibr"><sup>87</sup></xref>. Los virus pueden acceder al SNC por 2 v&#x000ed;as, la hemat&#x000f3;gena, un virus infectar&#x000e1; las c&#x000e9;lulas endoteliales de la barrera hematoencef&#x000e1;lica y la neuronal, aunque tambi&#x000e9;n podr&#x000ed;a diseminarse localmente a trav&#x000e9;s de la placa cribiforme del hueso etmoides Sin embargo, cruzar la barrera hematoencef&#x000e1;lica<xref rid="bib0885" ref-type="bibr"><sup>88</sup></xref> es poco probable por el SARS-CoV-2 debido al tama&#x000f1;o de este virus, por lo que es m&#x000e1;s probable que acceda a trav&#x000e9;s del nervio olfatorio o del trig&#x000e9;mino, de manera que la frecuencia de alteraciones olfatorias en la epidemia podr&#x000ed;a ser un indicaci&#x000f3;n de penetraci&#x000f3;n en el SNC. En el modelo de MHV-CoV, as&#x000ed; como el hallazgo de CoV en el cerebro de pacientes puede sugerir que el virus pueda persistir durante per&#x000ed;odos prolongados sin ninguna enfermedad neurol&#x000f3;gica aparente y el cerebro podr&#x000ed;a ser un reservorio de virus<xref rid="bib0890" ref-type="bibr"><sup>89</sup></xref>.</p></sec><sec id="sec0030"><title>Conclusi&#x000f3;n</title><p id="par0045">Los CoV son virus que pueden penetrar en el SNC y generar da&#x000f1;o, as&#x000ed; como mantenerse en &#x000e9;l como reservorio. Aunque la presencia de s&#x000ed;ntomas neurol&#x000f3;gicos es baja, su existencia puede justificar el paso del virus y la posibilidad de cl&#x000ed;nica neurol&#x000f3;gica precoz o tard&#x000ed;a con mayor incidencia. En este sentido, los potenciales cuadros neurol&#x000f3;gicos que podr&#x000ed;an hallarse podr&#x000ed;an agruparse en los siguientes: 1) Cuadros asociados a las consecuencias del cuadro infeccioso como el ictus isqu&#x000e9;mico, aunque la presencia de hemorragia cerebral podr&#x000ed;a asociarse a la acci&#x000f3;n del virus sobre el receptor de ACE2; 2) Cuadros asociados a enfermedades oportunistas como se ha observado en las otras epidemias; 3) Cuadros neurol&#x000f3;gicos asociados al paciente cr&#x000ed;tico, en aquellos que ingresan en las unidades de intensivos, espec&#x000ed;ficamente alteraciones musculares o rabdomi&#x000f3;lisis; 4) Cuadros asociados a la invasi&#x000f3;n del virus en territorios neur&#x000f3;genos o musculares como las alteraciones olfatorias (olfato y gusto) o miositis y 5) Cuadros no clasificables todav&#x000ed;a debido a la falta de informaci&#x000f3;n como son las alucinaciones. El seguimiento de los pacientes de la epidemia debe atender con cuidado a la evaluaci&#x000f3;n del SNC, tanto desde el punto de vista cl&#x000ed;nico como pron&#x000f3;stico.</p></sec></body><back><ref-list id="bibl0005"><title>Bibliograf&#x000ed;a</title><ref id="bib0450"><label>1</label><element-citation publication-type="journal" id="sbref0450"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Muth</surname><given-names>D.</given-names></name><name><surname>Niemeyer</surname><given-names>D.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name></person-group><article-title>Hosts and Sources of Endemic Human Coronaviruses</article-title><source>Adv Virus Res</source><volume>100</volume><year>2018</year><fpage>163</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/bs.aivir.2018.01.001</pub-id><pub-id pub-id-type="pmid">29551135</pub-id></element-citation></ref><ref id="bib0455"><label>2</label><element-citation publication-type="journal" id="sbref0455"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group><article-title>The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: A foreseeable medical challenge in post-HAART era</article-title><source>J Neuroimmune Pharmacol</source><volume>4</volume><year>2009</year><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1007/s11481-008-9136-0</pub-id><pub-id pub-id-type="pmid">19016329</pub-id></element-citation></ref><ref id="bib0460"><label>3</label><element-citation publication-type="journal" id="sbref0460"><person-group person-group-type="author"><name><surname>Brask</surname><given-names>J.</given-names></name><name><surname>Chauhan</surname><given-names>A.</given-names></name><name><surname>Hill</surname><given-names>R.H.</given-names></name><name><surname>Ljunggren</surname><given-names>H.G.</given-names></name><name><surname>Kristensson</surname><given-names>K.</given-names></name></person-group><article-title>Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins</article-title><source>J Neurovirol</source><volume>11</volume><year>2005</year><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1080/13550280500186916</pub-id><pub-id pub-id-type="pmid">16162482</pub-id></element-citation></ref><ref id="bib0465"><label>4</label><element-citation publication-type="journal" id="sbref0465"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>Y.</given-names></name><name><surname>Hotta</surname><given-names>H.</given-names></name><name><surname>Nishimura</surname><given-names>A.</given-names></name><name><surname>Tatsuno</surname><given-names>Y.</given-names></name><name><surname>Homma</surname><given-names>M.</given-names></name></person-group><article-title>Detection of measles virus nucleoprotein mRNA in autopsied brain tissues</article-title><source>J Gen Virol</source><volume>76</volume><year>1995</year><fpage>3201</fpage><lpage>3204</lpage><pub-id pub-id-type="pmid">8847530</pub-id></element-citation></ref><ref id="bib0470"><label>5</label><element-citation publication-type="journal" id="sbref0470"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group><article-title>The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: A foreseeable medical challenge in post-HAART era</article-title><source>J Neuroimmune Pharmacol</source><volume>4</volume><year>2009</year><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1007/s11481-008-9136-0</pub-id><pub-id pub-id-type="pmid">19016329</pub-id></element-citation></ref><ref id="bib0475"><label>6</label><element-citation publication-type="journal" id="sbref0475"><person-group person-group-type="author"><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>le Coupanec</surname><given-names>A.</given-names></name><name><surname>Stodola</surname><given-names>J.K.</given-names></name><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis</article-title><source>Virus Res</source><volume>194</volume><year>2014</year><fpage>145</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">25281913</pub-id></element-citation></ref><ref id="bib0480"><label>7</label><element-citation publication-type="journal" id="sbref0480"><person-group person-group-type="author"><name><surname>Bohmwald</surname><given-names>K.</given-names></name><name><surname>G&#x000e1;lvez</surname><given-names>N.M.S.</given-names></name><name><surname>R&#x000ed;os</surname><given-names>M.</given-names></name><name><surname>Kalergis</surname><given-names>A.M.</given-names></name></person-group><article-title>Neurologic Alterations Due to Respiratory Virus Infections</article-title><source>Front Cell Neurosci</source><volume>12</volume><year>2018</year><fpage>386</fpage><pub-id pub-id-type="doi">10.3389/fncel.2018.00386</pub-id><pub-id pub-id-type="pmid">30416428</pub-id></element-citation></ref><ref id="bib0485"><label>8</label><element-citation publication-type="journal" id="sbref0485"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>Day</surname><given-names>R.</given-names></name><name><surname>Newcombe</surname><given-names>J.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Neuroinvasion by human respiratory coronaviruses</article-title><source>J Virol</source><volume>74</volume><year>2000</year><fpage>8913</fpage><lpage>8921</lpage><pub-id pub-id-type="pmid">10982334</pub-id></element-citation></ref><ref id="bib0490"><label>9</label><element-citation publication-type="journal" id="sbref0490"><person-group person-group-type="author"><name><surname>Fazzini</surname><given-names>E.</given-names></name><name><surname>Fleming</surname><given-names>J.</given-names></name><name><surname>Fahn</surname><given-names>S.</given-names></name></person-group><article-title>Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease</article-title><source>Mov Disord</source><volume>7</volume><year>1992</year><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">1316552</pub-id></element-citation></ref><ref id="bib0495"><label>10</label><element-citation publication-type="journal" id="sbref0495"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>R.</given-names></name><name><surname>Wen</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name></person-group><article-title>Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children</article-title><source>Intervirology</source><volume>59</volume><year>2016</year><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1159/000453066</pub-id><pub-id pub-id-type="pmid">28103598</pub-id></element-citation></ref><ref id="bib0500"><label>11</label><element-citation publication-type="journal" id="sbref0500"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>E.A.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>M.E.</given-names></name><name><surname>Duffner</surname><given-names>P.K.</given-names></name><name><surname>Faden</surname><given-names>H.</given-names></name></person-group><article-title>Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis</article-title><source>Pediatrics</source><volume>113</volume><year>2004</year><fpage>e73</fpage><lpage>e76</lpage><pub-id pub-id-type="pmid">14702500</pub-id></element-citation></ref><ref id="bib0505"><label>12</label><element-citation publication-type="journal" id="sbref0505"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>K.K.</given-names></name><name><surname>Yu</surname><given-names>W.C.</given-names></name><name><surname>Chu</surname><given-names>C.M.</given-names></name><name><surname>Lau</surname><given-names>S.T.</given-names></name><name><surname>Sheng</surname><given-names>B.</given-names></name><name><surname>Yuen</surname><given-names>K.Y.</given-names></name></person-group><article-title>Possible central nervous system infection by SARS coronavirus</article-title><source>Emerg Infect Dis</source><volume>10</volume><year>2004</year><fpage>342</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.3201/eid1002.030638</pub-id><pub-id pub-id-type="pmid">15030709</pub-id></element-citation></ref><ref id="bib0510"><label>13</label><element-citation publication-type="journal" id="sbref0510"><person-group person-group-type="author"><name><surname>Turgay</surname><given-names>C.</given-names></name><name><surname>Emine</surname><given-names>T.</given-names></name><name><surname>Ozlem</surname><given-names>K.</given-names></name><name><surname>Muhammet</surname><given-names>S.P.</given-names></name><name><surname>Haydar</surname><given-names>A.T.</given-names></name></person-group><article-title>A rare cause of acute flaccid paralysis: Human coronaviruses</article-title><source>J. Pediatr. Neurosci</source><volume>10</volume><year>2015</year><fpage>280</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.4103/1817-1745.165716</pub-id><pub-id pub-id-type="pmid">26557177</pub-id></element-citation></ref><ref id="bib0515"><label>14</label><element-citation publication-type="journal" id="sbref0515"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Tengsupakul</surname><given-names>S.</given-names></name><name><surname>Sanchez</surname><given-names>O.</given-names></name><name><surname>Phaltas</surname><given-names>R.</given-names></name><name><surname>Maertens</surname><given-names>P.</given-names></name></person-group><article-title>Guillain-Barre syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report</article-title><source>SAGE Open Med. Case Rep</source><volume>7</volume><year>2019</year><pub-id pub-id-type="doi">10.1177/2050313X19838750</pub-id></element-citation></ref><ref id="bib0520"><label>15</label><element-citation publication-type="journal" id="sbref0520"><person-group person-group-type="author"><name><surname>Algahtani</surname><given-names>H.</given-names></name><name><surname>Subahi</surname><given-names>A.</given-names></name><name><surname>Shirah</surname><given-names>B.</given-names></name></person-group><article-title>Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature</article-title><source>Case Rep Neurol Med</source><volume>2016</volume><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/3502683</pub-id><comment>3502683</comment></element-citation></ref><ref id="bib0525"><label>16</label><element-citation publication-type="journal" id="sbref0525"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>E.A.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>M.E.</given-names></name><name><surname>Duffner</surname><given-names>P.K.</given-names></name><name><surname>Faden</surname><given-names>H.</given-names></name></person-group><article-title>Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis</article-title><source>Pediatrics</source><volume>113</volume><year>2004</year><fpage>e73</fpage><lpage>e76</lpage><pub-id pub-id-type="doi">10.1542/peds.113.1.e73</pub-id><pub-id pub-id-type="pmid">14702500</pub-id></element-citation></ref><ref id="bib0530"><label>17</label><element-citation publication-type="journal" id="sbref0530"><person-group person-group-type="author"><name><surname>McGavern</surname><given-names>D.B.</given-names></name><name><surname>Kang</surname><given-names>S.S.</given-names></name></person-group><article-title>Illuminating viral infections in the nervous system</article-title><source>Nat Rev Immunol</source><volume>11</volume><year>2011</year><fpage>318</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1038/nri2971</pub-id><pub-id pub-id-type="pmid">21508982</pub-id></element-citation></ref><ref id="bib0535"><label>18</label><element-citation publication-type="journal" id="sbref0535"><person-group person-group-type="author"><name><surname>Jacomy</surname><given-names>H.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Vacuolating encephalitis in mice infected by human coronavirus OC43</article-title><source>Virology</source><volume>315</volume><year>2003</year><fpage>20</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/S0042-6822(03)00323-4</pub-id><pub-id pub-id-type="pmid">14592756</pub-id></element-citation></ref><ref id="bib0540"><label>19</label><element-citation publication-type="journal" id="sbref0540"><person-group person-group-type="author"><name><surname>Jacomy</surname><given-names>H.</given-names></name><name><surname>Fragoso</surname><given-names>G.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name><name><surname>Mushynski</surname><given-names>W.E.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice</article-title><source>Virology</source><volume>349</volume><year>2006</year><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.01.049</pub-id><pub-id pub-id-type="pmid">16527322</pub-id></element-citation></ref><ref id="bib0545"><label>20</label><element-citation publication-type="journal" id="sbref0545"><person-group person-group-type="author"><name><surname>Dub&#x000e9;</surname><given-names>M.</given-names></name><name><surname>le Coupanec</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>A.H.M.</given-names></name><name><surname>Rini</surname><given-names>J.M.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43</article-title><source>J Virol</source><volume>92</volume><year>2018</year><fpage>e00404</fpage><lpage>e418</lpage><pub-id pub-id-type="other">10.1128/JVI. 00404-18</pub-id><pub-id pub-id-type="pmid">29925652</pub-id></element-citation></ref><ref id="bib0550"><label>21</label><element-citation publication-type="journal" id="sbref0550"><person-group person-group-type="author"><name><surname>Favreau</surname><given-names>D.J.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>St-Jean</surname><given-names>J.R.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>A human coronavirus OC43 variant harboring persistence-associated mutations in the S glycoprotein differentially induces the unfolded protein response in human neurons as compared to wild-type virus</article-title><source>Virology</source><volume>395</volume><year>2009</year><fpage>255</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.09.026</pub-id><pub-id pub-id-type="pmid">19846189</pub-id></element-citation></ref><ref id="bib0555"><label>22</label><element-citation publication-type="journal" id="sbref0555"><person-group person-group-type="author"><name><surname>Favreau</surname><given-names>D.J.</given-names></name><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronavirus-induced neuronal programmed cell death is cyclophilin D dependent and potentially caspase dispensable</article-title><source>J Virol</source><volume>86</volume><year>2012</year><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="other">10.1128/JVI. 06062-11</pub-id><pub-id pub-id-type="pmid">22013052</pub-id></element-citation></ref><ref id="bib0560"><label>23</label><element-citation publication-type="journal" id="sbref0560"><person-group person-group-type="author"><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>le Coupanec</surname><given-names>A.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Pivotal Role of Receptor-Interacting Protein Kinase 1 and Mixed Lineage Kinase Domain-Like in Neuronal Cell Death Induced by the Human Neuroinvasive Coronavirus OC43</article-title><source>J Virol</source><year>2016</year><fpage>91</fpage><pub-id pub-id-type="other">10.1128/JVI. 01513-1</pub-id></element-citation></ref><ref id="bib0565"><label>24</label><element-citation publication-type="journal" id="sbref0565"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>K.B.</given-names></name><name><surname>Calik</surname><given-names>M.</given-names></name><name><surname>Karal</surname><given-names>Y.</given-names></name><name><surname>Isikay</surname><given-names>S.</given-names></name><name><surname>Kocak</surname><given-names>O.</given-names></name><name><surname>Ozcelik</surname><given-names>A.</given-names></name></person-group><article-title>Viral etiological causes of febrile seizures for respiratory pathogens (EFES Study)</article-title><source>Hum Vaccin Immunother</source><volume>15</volume><year>2019</year><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="other">10.1080/21645515.2018.1526588. E</pub-id><pub-id pub-id-type="pmid">30235060</pub-id></element-citation></ref><ref id="bib0570"><label>25</label><element-citation publication-type="journal" id="sbref0570"><person-group person-group-type="author"><name><surname>Morfopoulou</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>J.R.</given-names></name><name><surname>Davies</surname><given-names>E.G.</given-names></name><name><surname>Anderson</surname><given-names>G.</given-names></name><name><surname>Virasami</surname><given-names>A.</given-names></name><name><surname>Qasim</surname><given-names>W.</given-names></name></person-group><article-title>Human coronavirus OC43 associated with fatal encephalitis</article-title><source>N Engl J Med</source><volume>375</volume><year>2016</year><fpage>497</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1509458</pub-id><pub-id pub-id-type="pmid">27518687</pub-id></element-citation></ref><ref id="bib0575"><label>26</label><element-citation publication-type="journal" id="sbref0575"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A.</given-names></name></person-group><article-title>R. Human macrophages are susceptible to coronavirus OC43</article-title><source>Adv Exp Med Biol</source><volume>440</volume><year>1998</year><fpage>635</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">9782339</pub-id></element-citation></ref><ref id="bib0580"><label>27</label><element-citation publication-type="journal" id="sbref0580"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>S.</given-names></name><name><surname>Macnaughton</surname><given-names>M.</given-names></name></person-group><article-title>R. Replication of human respiratory coronavirus strain 229E in human macrophages</article-title><source>J Gen Virol</source><volume>60</volume><year>1982</year><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">7108490</pub-id></element-citation></ref><ref id="bib0585"><label>28</label><element-citation publication-type="journal" id="sbref0585"><person-group person-group-type="author"><collab>Who Mers-Cov Research Group</collab></person-group><article-title>State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans</article-title><source>PLoS Curr.</source><volume>5</volume><year>2013</year><comment>doi: 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8</comment></element-citation></ref><ref id="bib0590"><label>29</label><element-citation publication-type="journal" id="sbref0590"><person-group person-group-type="author"><name><surname>Saad</surname><given-names>M.</given-names></name><name><surname>Omrani</surname><given-names>A.S.</given-names></name><name><surname>Baig</surname><given-names>K.</given-names></name><name><surname>Bahloul</surname><given-names>A.</given-names></name><name><surname>Elzein</surname><given-names>F.</given-names></name><name><surname>Matin</surname><given-names>M.A.</given-names></name></person-group><article-title>Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia</article-title><source>Int J Infect Dis</source><volume>29</volume><year>2014</year><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">25303830</pub-id></element-citation></ref><ref id="bib0595"><label>30</label><element-citation publication-type="journal" id="sbref0595"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>Y.M.</given-names></name><name><surname>Harthi</surname><given-names>A.</given-names></name><name><surname>Hussein</surname><given-names>J.</given-names></name><name><surname>Bouchama</surname><given-names>A.</given-names></name><name><surname>Johani</surname><given-names>S.</given-names></name><name><surname>Hajeer</surname><given-names>A.H.</given-names></name></person-group><article-title>Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)</article-title><source>Infection</source><volume>43</volume><year>2015</year><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">25600929</pub-id></element-citation></ref><ref id="bib0600"><label>31</label><element-citation publication-type="journal" id="sbref0600"><person-group person-group-type="author"><name><surname>Algahtani</surname><given-names>H.</given-names></name><name><surname>Subahi</surname><given-names>A.</given-names></name><name><surname>Shirah</surname><given-names>B.</given-names></name></person-group><article-title>Neurological complications of Middle East respiratory syndrome coronavirus: A report of two cases and review of the literature</article-title><source>Case Rep Neurol Med</source><volume>2016</volume><year>2016</year><comment>3502683</comment></element-citation></ref><ref id="bib0605"><label>32</label><element-citation publication-type="journal" id="sbref0605"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Heo</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.O.</given-names></name><name><surname>Song</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>S.S.</given-names></name><name><surname>Park</surname><given-names>T.H.</given-names></name></person-group><article-title>Neurological Complications during Treatment of Middle East Respiratory Syndrome</article-title><source>J Clin Neurol</source><volume>13</volume><year>2017</year><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.3988/jcn.2017.13.3.227</pub-id><pub-id pub-id-type="pmid">28748673</pub-id></element-citation></ref><ref id="bib0610"><label>33</label><element-citation publication-type="journal" id="sbref0610"><person-group person-group-type="author"><name><surname>Al-Hameed</surname><given-names>F.M.</given-names></name></person-group><article-title>Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus</article-title><source>Saudi Med J</source><volume>38</volume><year>2017</year><fpage>196</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.15537/smj.2017.2.16255</pub-id><pub-id pub-id-type="pmid">28133694</pub-id></element-citation></ref><ref id="bib0615"><label>34</label><element-citation publication-type="journal" id="sbref0615"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Chan</surname><given-names>K.H.</given-names></name><name><surname>Choi</surname><given-names>G.K.</given-names></name><name><surname>To</surname><given-names>K.K.</given-names></name><name><surname>Tse</surname><given-names>H.</given-names></name><name><surname>Cai</surname><given-names>J.P.</given-names></name></person-group><article-title>Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: Implications for disease pathogenesis and clinical manifestation</article-title><source>J Infect Dis</source><volume>207</volume><year>2013</year><fpage>1743</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">23532101</pub-id></element-citation></ref><ref id="bib0620"><label>35</label><element-citation publication-type="journal" id="sbref0620"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>P.J.</given-names></name><name><surname>Arnold</surname><given-names>D.</given-names></name><name><surname>Antel</surname><given-names>J.P.</given-names></name></person-group><article-title>Virus-induced autoimmune reactions in the CNS</article-title><source>Curr Top Microbiol Immunol</source><volume>253</volume><year>2001</year><fpage>247</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">11417138</pub-id></element-citation></ref><ref id="bib0625"><label>36</label><element-citation publication-type="journal" id="sbref0625"><person-group person-group-type="author"><name><surname>Leland</surname><given-names>D.S.</given-names></name><name><surname>Ginocchio</surname><given-names>C.C.</given-names></name></person-group><article-title>Role of cell culture for virus detection in the age of technology</article-title><source>Clin Microbiol Rev</source><volume>20</volume><year>2007</year><fpage>49</fpage><lpage>78</lpage><pub-id pub-id-type="other">10.1128/CMR. 00002-06</pub-id><pub-id pub-id-type="pmid">17223623</pub-id></element-citation></ref><ref id="bib0630"><label>37</label><element-citation publication-type="journal" id="sbref0630"><person-group person-group-type="author"><name><surname>Stainsby</surname><given-names>B.</given-names></name><name><surname>Howitt</surname><given-names>S.</given-names></name><name><surname>Porr</surname><given-names>J.</given-names></name></person-group><article-title>Neuromusculoskeletal disorders following&#x000a0;SARS: A case series</article-title><source>J Can Chiropr Assoc</source><volume>55</volume><year>2011</year><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21403780</pub-id></element-citation></ref><ref id="bib0635"><label>38</label><element-citation publication-type="journal" id="sbref0635"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>C.C.</given-names></name></person-group><article-title>Peripheral nerve disease in SARS: Report of a case</article-title><source>Neurology</source><volume>61</volume><year>2003</year><fpage>1820</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">14694063</pub-id></element-citation></ref><ref id="bib0640"><label>39</label><element-citation publication-type="journal" id="sbref0640"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>L.K.</given-names></name><name><surname>Hsieh</surname><given-names>S.T.</given-names></name><name><surname>Chao</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>Y.C.</given-names></name><name><surname>Lin</surname><given-names>Y.H.</given-names></name><name><surname>Chang</surname><given-names>S.C.</given-names></name></person-group><article-title>Neuromuscular disorders in severe acute respiratory syndrome</article-title><source>Arch Neurol</source><volume>61</volume><year>2004</year><fpage>1669</fpage><lpage>1673</lpage><pub-id pub-id-type="pmid">15534177</pub-id></element-citation></ref><ref id="bib0645"><label>40</label><element-citation publication-type="journal" id="sbref0645"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>T.W.</given-names></name><name><surname>Wong</surname><given-names>K.S.</given-names></name><name><surname>Hui</surname><given-names>A.C.</given-names></name><name><surname>To</surname><given-names>K.F.</given-names></name><name><surname>Lai</surname><given-names>S.T.</given-names></name><name><surname>Ng</surname><given-names>W.F.</given-names></name></person-group><article-title>Myopathic changes associated with severe acute respiratory syndrome</article-title><source>Arch Neurol</source><volume>62</volume><year>2005</year><fpage>1113</fpage><lpage>1117</lpage><pub-id pub-id-type="pmid">16009768</pub-id></element-citation></ref><ref id="bib0650"><label>41</label><element-citation publication-type="journal" id="sbref0650"><person-group person-group-type="author"><name><surname>Rainer</surname><given-names>T.H.</given-names></name><name><surname>Lee</surname><given-names>N.</given-names></name><name><surname>Ip</surname><given-names>M.</given-names></name><name><surname>Galvani</surname><given-names>A.P.</given-names></name><name><surname>Antonio</surname><given-names>G.E.</given-names></name><name><surname>Wong</surname><given-names>K.T.</given-names></name></person-group><article-title>Features discriminating SARS from other severe viral respiratory tract infections</article-title><source>Eur J Clin Microbiol Infect Dis</source><volume>26</volume><year>2007</year><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">17219094</pub-id></element-citation></ref><ref id="bib0655"><label>42</label><element-citation publication-type="journal" id="sbref0655"><person-group person-group-type="author"><name><surname>Umapathi</surname><given-names>T.</given-names></name><name><surname>Kor</surname><given-names>A.C.</given-names></name><name><surname>Venketasubramanian</surname><given-names>N.</given-names></name><name><surname>Lim</surname><given-names>C.C.</given-names></name><name><surname>Pang</surname><given-names>B.C.</given-names></name><name><surname>Yeo</surname><given-names>T.T.</given-names></name></person-group><article-title>Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)</article-title><source>J Neurol</source><volume>251</volume><year>2004</year><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">15503102</pub-id></element-citation></ref><ref id="bib0660"><label>43</label><element-citation publication-type="journal" id="sbref0660"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>L.K.</given-names></name><name><surname>Hsieh</surname><given-names>S.T.</given-names></name><name><surname>Chang</surname><given-names>Y.C.</given-names></name></person-group><article-title>Neurological manifestations in severe acute respiratory syndrome</article-title><source>Acta Neurol Taiwan</source><volume>14</volume><year>2005</year><fpage>113</fpage><lpage>119</lpage><comment>Abstract</comment><pub-id pub-id-type="pmid">16252612</pub-id></element-citation></ref><ref id="bib0665"><label>44</label><element-citation publication-type="journal" id="sbref0665"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Virus-induced autoimmunity in multiple sclerosis: The coronavirus paradigm</article-title><source>Adv Clin Neurosci</source><volume>7</volume><year>1997</year><fpage>215</fpage><lpage>233</lpage></element-citation></ref><ref id="bib0670"><label>45</label><element-citation publication-type="journal" id="sbref0670"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Iwasaki</surname><given-names>Y.</given-names></name><name><surname>Koprowski</surname><given-names>H.</given-names></name></person-group><article-title>Intracisternal virus-like particles in brain of a multiple sclerosis patient</article-title><source>J Neurol Sci</source><volume>28</volume><year>1976</year><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">932771</pub-id></element-citation></ref><ref id="bib0675"><label>46</label><element-citation publication-type="journal" id="sbref0675"><person-group person-group-type="author"><name><surname>Burks</surname><given-names>J.S.</given-names></name><name><surname>DeVald</surname><given-names>B.L.</given-names></name><name><surname>Jankovsky</surname><given-names>L.D.</given-names></name><name><surname>Gerdes</surname><given-names>J.</given-names></name></person-group><article-title>C. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients</article-title><source>Science</source><volume>209</volume><year>1980</year><fpage>933</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">7403860</pub-id></element-citation></ref><ref id="bib0680"><label>47</label><element-citation publication-type="journal" id="sbref0680"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>R.S.</given-names></name><name><surname>Brown</surname><given-names>B.</given-names></name><name><surname>Brian</surname><given-names>D.</given-names></name><name><surname>Cabirac</surname><given-names>G.F.</given-names></name></person-group><article-title>Detection of coronavirus RNA and antigen in multiple sclerosis brain</article-title><source>Ann Neurol</source><volume>31</volume><year>1992</year><fpage>525</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">1596089</pub-id></element-citation></ref><ref id="bib0685"><label>48</label><element-citation publication-type="journal" id="sbref0685"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>J.N.</given-names></name><name><surname>Mounir</surname><given-names>S.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronavirus gene expression in the brains of multiple sclerosis patients</article-title><source>Virology</source><volume>191</volume><year>1992</year><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">1413524</pub-id></element-citation></ref><ref id="bib0690"><label>49</label><element-citation publication-type="journal" id="sbref0690"><person-group person-group-type="author"><name><surname>Dessau</surname><given-names>R.B.</given-names></name><name><surname>Lisby</surname><given-names>G.</given-names></name><name><surname>Frederiksen</surname><given-names>J.L.</given-names></name></person-group><article-title>Coronaviruses in brain tissue from patients with multiple sclerosis</article-title><source>Acta Neuropathol</source><volume>101</volume><year>2001</year><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">11515789</pub-id></element-citation></ref><ref id="bib0695"><label>50</label><element-citation publication-type="journal" id="sbref0695"><person-group person-group-type="author"><name><surname>Salmi</surname><given-names>A.</given-names></name><name><surname>Ziola</surname><given-names>B.</given-names></name><name><surname>Hovi</surname><given-names>T.</given-names></name><name><surname>Reunanen</surname><given-names>M.</given-names></name></person-group><article-title>Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients</article-title><source>Neurology</source><volume>32</volume><year>1982</year><fpage>292</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">6278362</pub-id></element-citation></ref><ref id="bib0700"><label>51</label><element-citation publication-type="journal" id="sbref0700"><person-group person-group-type="author"><name><surname>Cristallo</surname><given-names>A.</given-names></name><name><surname>Gambaro</surname><given-names>F.</given-names></name><name><surname>Biamonti</surname><given-names>G.</given-names></name><name><surname>Ferrante</surname><given-names>P.</given-names></name><name><surname>Battaglia</surname><given-names>M.</given-names></name><name><surname>Cereda</surname><given-names>P.M.</given-names></name></person-group><article-title>Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients</article-title><source>Microbiologica.</source><volume>2</volume><year>1997</year><fpage>105</fpage><lpage>114</lpage></element-citation></ref><ref id="bib0705"><label>52</label><element-citation publication-type="journal" id="sbref0705"><person-group person-group-type="author"><name><surname>Bonavia</surname><given-names>A.</given-names></name><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>Yong</surname><given-names>V.W.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43</article-title><source>J Virol</source><volume>71</volume><year>1997</year><fpage>800</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">8985420</pub-id></element-citation></ref><ref id="bib0710"><label>53</label><element-citation publication-type="journal" id="sbref0710"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>G.</given-names></name><name><surname>Lachance</surname><given-names>C.</given-names></name><name><surname>Tardieu</surname><given-names>M.</given-names></name><name><surname>Cashman</surname><given-names>N.R.</given-names></name><name><surname>Talbot</surname><given-names>P.</given-names></name></person-group><article-title>J. Acute and persistent infection of human neural cell lines by human coronavirus OC43</article-title><source>J Virol</source><volume>73</volume><year>1999</year><fpage>3338</fpage><lpage>3350</lpage><pub-id pub-id-type="pmid">10074188</pub-id></element-citation></ref><ref id="bib0715"><label>54</label><element-citation publication-type="journal" id="sbref0715"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>&#x000c9;kand&#x000e9;</surname><given-names>S.</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>G.</given-names></name><name><surname>Lachance</surname><given-names>C.</given-names></name><name><surname>Chagnon</surname><given-names>F.</given-names></name><name><surname>Tardieu</surname><given-names>M.</given-names></name></person-group><article-title>J. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E</article-title><source>J Virol</source><volume>73</volume><year>1999</year><fpage>3326</fpage><lpage>3337</lpage><pub-id pub-id-type="pmid">10074187</pub-id></element-citation></ref><ref id="bib0720"><label>55</label><element-citation publication-type="journal" id="sbref0720"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>O.</given-names></name><name><surname>Lygner</surname><given-names>P.E.</given-names></name><name><surname>Bergstrom</surname><given-names>T.</given-names></name><name><surname>Andersson</surname><given-names>M.</given-names></name><name><surname>Vahlne</surname><given-names>A.</given-names></name></person-group><article-title>Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study</article-title><source>J Neurol</source><volume>240</volume><year>1993</year><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">8410082</pub-id></element-citation></ref><ref id="bib0725"><label>56</label><element-citation publication-type="journal" id="sbref0725"><person-group person-group-type="author"><name><surname>Sibley</surname><given-names>W.A.</given-names></name><name><surname>Bamford</surname><given-names>C.R.</given-names></name><name><surname>Clark</surname><given-names>K.</given-names></name></person-group><article-title>Clinical viral infections and multiple sclerosis</article-title><source>Lancet</source><volume>1</volume><year>1985</year><fpage>1313</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">2860501</pub-id></element-citation></ref><ref id="bib0730"><label>57</label><element-citation publication-type="journal" id="sbref0730"><person-group person-group-type="author"><name><surname>Barthold</surname><given-names>S.W.</given-names></name><name><surname>Smith</surname><given-names>A.L.</given-names></name></person-group><article-title>Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice</article-title><source>Arch Virol</source><volume>122</volume><year>1992</year><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">1309644</pub-id></element-citation></ref><ref id="bib0735"><label>58</label><element-citation publication-type="journal" id="sbref0735"><person-group person-group-type="author"><name><surname>Buchmeier</surname><given-names>M.J.</given-names></name><name><surname>Dalziel</surname><given-names>R.G.</given-names></name><name><surname>Koolen</surname><given-names>M.J.</given-names></name><name><surname>Lampert</surname><given-names>P.W.</given-names></name></person-group><article-title>Molecular determinants of CNS virulence of MHV-4</article-title><source>Adv Exp Med Biol</source><volume>218</volume><year>1987</year><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/978-1-4684-1280-2_38</pub-id><pub-id pub-id-type="pmid">2829542</pub-id></element-citation></ref><ref id="bib0740"><label>59</label><element-citation publication-type="journal" id="sbref0740"><person-group person-group-type="author"><name><surname>Hosking</surname><given-names>M.P.</given-names></name><name><surname>Lane</surname><given-names>T.E.</given-names></name></person-group><article-title>The pathogenesis of murine coronavirus infection of the central nervous system</article-title><source>Crit Rev Immunol</source><volume>30</volume><year>2010</year><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1615/CritRevImmunol.v30.i2.20</pub-id><pub-id pub-id-type="pmid">20370625</pub-id></element-citation></ref><ref id="bib0745"><label>60</label><element-citation publication-type="journal" id="sbref0745"><person-group person-group-type="author"><name><surname>Lavi</surname><given-names>E.</given-names></name><name><surname>Fishman</surname><given-names>P.S.</given-names></name><name><surname>Highkin</surname><given-names>M.K.</given-names></name><name><surname>Weiss</surname><given-names>S.R.</given-names></name></person-group><article-title>Limbic encephalitis after inhalation of a murine coronavirus</article-title><source>Lab Investig</source><volume>58</volume><year>1988</year><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">2826881</pub-id></element-citation></ref><ref id="bib0750"><label>61</label><element-citation publication-type="journal" id="sbref0750"><person-group person-group-type="author"><name><surname>Cabirac</surname><given-names>G.F.</given-names></name><name><surname>Soike</surname><given-names>K.F.</given-names></name><name><surname>Zhang</surname><given-names>J.Y.</given-names></name><name><surname>Hoel</surname><given-names>K.</given-names></name><name><surname>Butunoi</surname><given-names>C.</given-names></name><name><surname>Cai</surname><given-names>G.Y.</given-names></name></person-group><article-title>Entry of coronavirus into primate CNS following peripheral infection</article-title><source>Microb Pathog</source><volume>16</volume><year>1994</year><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">7815918</pub-id></element-citation></ref><ref id="bib0755"><label>62</label><element-citation publication-type="journal" id="sbref0755"><person-group person-group-type="author"><name><surname>Bleau</surname><given-names>C.</given-names></name><name><surname>Filliol</surname><given-names>A.</given-names></name><name><surname>Samson</surname><given-names>M.</given-names></name><name><surname>Lamontagne</surname><given-names>L.</given-names></name></person-group><article-title>Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells</article-title><source>J Virol</source><volume>89</volume><year>2015</year><fpage>9896</fpage><lpage>9908</lpage><pub-id pub-id-type="other">10.1128/JVI. 01501-15</pub-id><pub-id pub-id-type="pmid">26202229</pub-id></element-citation></ref><ref id="bib0760"><label>63</label><element-citation publication-type="journal" id="sbref0760"><person-group person-group-type="author"><name><surname>Savarin</surname><given-names>C.</given-names></name><name><surname>Bergmann</surname><given-names>C.C.</given-names></name></person-group><article-title>Fine Tuning the Cytokine Storm by IFN and IL-10 Following Neurotropic Coronavirus Encephalomyelitis</article-title><source>Front Immunol</source><volume>9</volume><year>2018</year><fpage>3022</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.03022</pub-id><pub-id pub-id-type="pmid">30619363</pub-id></element-citation></ref><ref id="bib0765"><label>64</label><element-citation publication-type="journal" id="sbref0765"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>D.</given-names></name><name><surname>Addya</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>R.S.</given-names></name><name><surname>Kenyon</surname><given-names>L.C.</given-names></name><name><surname>Choe</surname><given-names>A.</given-names></name><name><surname>Cohrs</surname><given-names>R.J.</given-names></name></person-group><article-title>Mouse hepatitis virus infection upregulates genes involved in innate immune responses</article-title><source>PLoS One</source><volume>9</volume><year>2014</year><fpage>e111351</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0111351</pub-id><pub-id pub-id-type="pmid">25360880</pub-id></element-citation></ref><ref id="bib0770"><label>65</label><element-citation publication-type="journal" id="sbref0770"><person-group person-group-type="author"><name><surname>Ceccarelli</surname><given-names>M.</given-names></name><name><surname>Berretta</surname><given-names>M.</given-names></name><name><surname>Venanzi Rullo</surname><given-names>E.</given-names></name><name><surname>Nunnari</surname><given-names>G.</given-names></name><name><surname>Cacopardo</surname><given-names>B.</given-names></name></person-group><article-title>Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2 Would a rose by another name smell as sweet?</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>24</volume><year>2020</year><fpage>2781</fpage><lpage>2783</lpage><pub-id pub-id-type="doi">10.26355/eurrev_202003_20551</pub-id><pub-id pub-id-type="pmid">32196628</pub-id></element-citation></ref><ref id="bib0775"><label>66</label><element-citation publication-type="journal" id="sbref0775"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name></person-group><article-title>Early Transmission Dynamics in Wuhan China, of Novel Coronavirus-Infected Pneumonia</article-title><source>Engl J Med</source><year>2020</year><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id></element-citation></ref><ref id="bib0780"><label>67</label><element-citation publication-type="journal" id="sbref0780"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses</article-title><source>Microbes Infect</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.micinf.2020.01.004</pub-id></element-citation></ref><ref id="bib0785"><label>68</label><element-citation publication-type="journal" id="sbref0785"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C.C.</given-names></name><name><surname>Shih</surname><given-names>T.P.</given-names></name><name><surname>Ko</surname><given-names>W.C.</given-names></name><name><surname>Tang</surname><given-names>H.J.</given-names></name><name><surname>Hsueh</surname><given-names>P.R.</given-names></name></person-group><article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</article-title><source>Int J Antimicrob Agents</source><year>2020</year><fpage>105924</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id><pub-id pub-id-type="pmid">32081636</pub-id></element-citation></ref><ref id="bib0790"><label>69</label><element-citation publication-type="journal" id="sbref0790"><person-group person-group-type="author"><name><surname>Perrella</surname><given-names>A.</given-names></name><name><surname>Carannante</surname><given-names>N.</given-names></name><name><surname>Berretta</surname><given-names>M.</given-names></name><name><surname>Rinaldi</surname><given-names>M.</given-names></name><name><surname>Maturo</surname><given-names>N.</given-names></name><name><surname>Rinaldi</surname><given-names>L.</given-names></name></person-group><article-title>Novel Coronavirus 2019 (Sars-CoV2): A global emergency that needs new approaches?</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>24</volume><year>2020</year><fpage>2162</fpage><lpage>2164</lpage><pub-id pub-id-type="doi">10.26355/eurrev_202002_20396</pub-id><pub-id pub-id-type="pmid">32141586</pub-id></element-citation></ref><ref id="bib0795"><label>70</label><element-citation publication-type="journal" id="sbref0795"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Du</surname><given-names>R.H.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Zheng</surname><given-names>X.S.</given-names></name><name><surname>Yang</surname><given-names>X.L.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name></person-group><article-title>Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes</article-title><source>Emerg Microbes Infect</source><volume>9</volume><year>2020</year><fpage>386</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">32065057</pub-id></element-citation></ref><ref id="bib0800"><label>71</label><element-citation publication-type="journal" id="sbref0800"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>F.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="bib0805"><label>72</label><element-citation publication-type="journal" id="sbref0805"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><year>2020</year><fpage>395497</fpage><lpage>395506</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id></element-citation></ref><ref id="bib0810"><label>73</label><element-citation publication-type="journal" id="sbref0810"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China</article-title><source>JAMA</source><year>2020</year><pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id></element-citation></ref><ref id="bib0815"><label>74</label><element-citation publication-type="journal" id="sbref0815"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.W.</given-names></name><name><surname>Wu</surname><given-names>X.X.</given-names></name><name><surname>Jiang</surname><given-names>X.G.</given-names></name><name><surname>Xu</surname><given-names>K.J.</given-names></name><name><surname>Ying</surname><given-names>L.J.</given-names></name><name><surname>Ma</surname><given-names>C.L.</given-names></name></person-group><article-title>Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series</article-title><source>BMJ</source><volume>368</volume><year>2020</year><fpage>606</fpage><pub-id pub-id-type="doi">10.1136/bmj.m606</pub-id></element-citation></ref><ref id="bib0820"><label>75</label><element-citation publication-type="journal" id="sbref0820"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Fang</surname><given-names>Y.Y.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>M.F.</given-names></name><name><surname>Ma</surname><given-names>J.P.</given-names></name></person-group><article-title>Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province</article-title><source>Chin Med J (Engl)</source><year>2020</year><pub-id pub-id-type="doi">10.1097/CM9.0000000000000744</pub-id></element-citation></ref><ref id="bib0825"><label>76</label><element-citation publication-type="journal" id="sbref0825"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Shu</surname><given-names>H.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study</article-title><source>Lancet Respir Med</source><year>2020</year><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30079-5</pub-id></element-citation></ref><ref id="bib0830"><label>77</label><mixed-citation publication-type="other" id="oref0385">Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A retrospective case series study. BMJ. DOI: 10.1101/2020.02.22.20026500.</mixed-citation></ref><ref id="bib0835"><label>78</label><element-citation publication-type="journal" id="sbref0835"><person-group person-group-type="author"><name><surname>Filatov</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Hindi</surname><given-names>F.</given-names></name><name><surname>Espinosa</surname><given-names>P.</given-names></name></person-group><article-title>Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy</article-title><source>Cureus</source><volume>12</volume><year>2020</year><fpage>e7352</fpage><pub-id pub-id-type="doi">10.7759/cureus.7352</pub-id><pub-id pub-id-type="pmid">32328364</pub-id></element-citation></ref><ref id="bib0840"><label>79</label><element-citation publication-type="journal" id="sbref0840"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.C.</given-names></name><name><surname>Bai</surname><given-names>W.Z.</given-names></name><name><surname>Hashikawa</surname><given-names>T.</given-names></name></person-group><article-title>The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients</article-title><source>J Med Virol</source><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.25728</pub-id></element-citation></ref><ref id="bib0845"><label>80</label><element-citation publication-type="journal" id="sbref0845"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>A.R.</given-names></name><name><surname>Perlman</surname><given-names>S.</given-names></name></person-group><article-title>Coronaviruses: An overview of their replication and pathogenesis</article-title><source>Methods Mol Biol</source><volume>1282</volume><year>2015</year><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">25720466</pub-id></element-citation></ref><ref id="bib0850"><label>81</label><element-citation publication-type="journal" id="sbref0850"><person-group person-group-type="author"><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Le Coupanec</surname><given-names>A.</given-names></name><name><surname>Brison</surname><given-names>E.</given-names></name><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Neuroinvasive and neurotropic human respiratory coronaviruses: Potential neurovirulent agents in humans</article-title><source>Adv Exp Med Biol</source><volume>807</volume><year>2014</year><fpage>75</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/978-81-322-1777-0_6</pub-id><pub-id pub-id-type="pmid">24619619</pub-id></element-citation></ref><ref id="bib0855"><label>82</label><element-citation publication-type="journal" id="sbref0855"><person-group person-group-type="author"><name><surname>Narayanan</surname><given-names>K.</given-names></name><name><surname>Ramirez</surname><given-names>S.I.</given-names></name><name><surname>Lokugamage</surname><given-names>K.G.</given-names></name><name><surname>Makino</surname><given-names>S.</given-names></name></person-group><article-title>Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression</article-title><source>Virus Res</source><volume>202</volume><year>2015</year><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">25432065</pub-id></element-citation></ref><ref id="bib0860"><label>83</label><element-citation publication-type="journal" id="sbref0860"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Kok</surname><given-names>K.H.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>To</surname><given-names>K.K.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name></person-group><article-title>Genomic characterization of the 2019 novel human-pathogenic&#x000a0;coronavirus&#x000a0;isolated from a patient with atypical pneumonia after visiting Wuhan</article-title><source>Emerg Microbes Infect</source><volume>9</volume><year>2020</year><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></element-citation></ref><ref id="bib0865"><label>84</label><element-citation publication-type="journal" id="sbref0865"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Zhang</surname><given-names>A.J.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name><name><surname>Poon</surname><given-names>V.K.</given-names></name><name><surname>Chan</surname><given-names>C.C.</given-names></name><name><surname>Lee</surname><given-names>A.C.</given-names></name></person-group><article-title>Simulation of the clinical and pathological manifestations of&#x000a0;Coronavirus&#x000a0;Disease 2019 (COVID-19) in golden Syrian hamster model: Implications for disease pathogenesis and transmissibility</article-title><source>Clin Infect Dis</source><volume>325</volume><year>2020</year><pub-id pub-id-type="doi">10.1093/cid/ciaa325</pub-id></element-citation></ref><ref id="bib0870"><label>85</label><element-citation publication-type="journal" id="sbref0870"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Sui</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>I.C.</given-names></name><name><surname>Kuhn</surname><given-names>J.H.</given-names></name><name><surname>Radoshitzky</surname><given-names>S.R.</given-names></name><name><surname>Marasco</surname><given-names>W.A.</given-names></name></person-group><article-title>The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2</article-title><source>Virology</source><volume>367</volume><year>2007</year><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2007.04.035</pub-id><pub-id pub-id-type="pmid">17631932</pub-id></element-citation></ref><ref id="bib0875"><label>86</label><element-citation publication-type="journal" id="sbref0875"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>A.M.</given-names></name><name><surname>Khaleeq</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>U.</given-names></name><name><surname>Syeda</surname><given-names>H.</given-names></name></person-group><article-title>Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution Host-Virus Interaction, and Proposed Neurotropic Mechanisms</article-title><source>CS Chem Neurosci</source><year>2020</year><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00122</pub-id></element-citation></ref><ref id="bib0880"><label>87</label><element-citation publication-type="journal" id="sbref0880"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>H.</given-names></name><name><surname>Geier</surname><given-names>M.</given-names></name><name><surname>Marzi</surname><given-names>A.</given-names></name><name><surname>Krumbiegel</surname><given-names>M.</given-names></name><name><surname>Peipp</surname><given-names>M.</given-names></name><name><surname>Fey</surname><given-names>G.H.</given-names></name></person-group><article-title>Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor</article-title><source>Biochem Biophys Res Commun</source><volume>319</volume><year>2004</year><fpage>1216</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.05.114</pub-id><pub-id pub-id-type="pmid">15194496</pub-id></element-citation></ref><ref id="bib0885"><label>88</label><element-citation publication-type="journal" id="sbref0885"><person-group person-group-type="author"><name><surname>Joob</surname><given-names>B.</given-names></name><name><surname>Wiwanitkit</surname><given-names>V.</given-names></name></person-group><article-title>Neurologic syndrome due to MERS: Is there a possibility that the virus can cross the blood-brain barrier to cause a neurological problem?</article-title><source>Ann Trop Med Public Health</source><volume>8</volume><year>2015</year><fpage>231</fpage><pub-id pub-id-type="doi">10.4103/1755-6783.162654</pub-id></element-citation></ref><ref id="bib0890"><label>89</label><element-citation publication-type="journal" id="sbref0890"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>O.</given-names></name><name><surname>Coulter-Mackie</surname><given-names>M.B.</given-names></name><name><surname>Puchalski</surname><given-names>S.</given-names></name><name><surname>Dales</surname><given-names>S.</given-names></name></person-group><article-title>In vivo&#x000a0;and&#x000a0;in vitro&#x000a0;models of demyelinating disease IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases</article-title><source>Virology</source><volume>137</volume><year>1984</year><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">6091333</pub-id></element-citation></ref></ref-list></back></article>